Archives for January 2008
A Filtration Collaboration: Delcath and Aethlon to Expand Cancer Treatment Options
Aethlon Medical and Delcath Systems have agreed to jointly research and develop a new filtration cartridge for use in Delcath’s percutaneous hepatic perfusion (”PHP”) system.
PHP is a technology designed to isolate and deliver high doses of anti-cancer agents to specific organs, while minimizing harmful drug exposure in the rest of the body.
One of the […]
Healthcare Reform 2008 - Evolution or Revolution?
Healthcare Reform 2008 - Evolution or Revolution?
Event to be hosted by the Executive Council
Tuesday, February 12, 2008
8:00AM - 11:00 AM
Harvard Club of New York
27 West 44th Street
New York, NY 10019
It now appears certain that healthcare reform will be high on the political agenda next year. The upcoming Presidential and Congressional elections promise to focus public and business leaders’ attention on proposals […]
BioSphere to Market Microspheres in China
Company eyes large opportunity in treating liver cancer
Rockland, MA-based BioSphere Medical reported this week that the Medical Device Department of the People’s Republic of China approved BioSphere’s Embosphere Microspheres for clinical use in treating vascular embolizations, arteriovenous malformations, hypervascularized tumors, and symptomatic uterine fibroids.
Approximately 200 million Chinese have health coverage, creating a market opportunity close […]
[Video Profile] Interview with John Seaberg, CEO of NeoChord
This interview with John Seaberg, CEO of NeoChord, is the first of many filmed earlier this month at the OMP Finance Forum.
NeoChord aims to significantly improve the surgical repair of mitral valve regurgitation through the use of minimally invasive surgical techniques for the implantation of artificial chordae tendineae. NeoChords’s new technology eliminates the need for […]
Bad Tasting Medicine a Thing of the Past?
While some might consider forcing down terrible-tasting cough syrup a right of passage, this childhood trauma may soon go the way of chicken pox.
Aversive taste is a leading factor in patient noncompliance with many prescribed liquid formulations of antibiotics, resulting in lack of efficacy and emergence of resistant infections. Many potentially useful formulations of medicines […]
Breast Cancer Screening Co-Pay Could Hurt Insurers’ Bottom Line
A new study in The New England Journal of Medicine found that a modest insurance co-pay was enough to deter many older women from getting potentially life-saving mammograms.
The study examined 366,475 women between the ages of 65 to 69 enrolled at 174 Medicare managed-care plans. Screening rates were 8.3% lower for women whose plans required […]
Luminex to Streamline Tyson’s Food Safety Network
As Tyson Food’s Richard Bond led an initiative to cut costs and improve earnings, he no doubt eyed the costly but necessary food safety and animal health division.
The company announced yesterday that it will collaborate with Luminex to create faster, more accurate and cost-effective food safety and animal health tests.
Tyson’s Food Safety Network comprises 17 […]
NovaDel NDA: Longs May Finally Get a Good Night’s Sleep
The FDA has accepted Flemington, NJ-based NovaDel Pharma’s New Drug Application for ZolpiMist. ZolpiMist is an oral spray for the short-term treatment of insomnia. The company anticipates the FDA will complete its review by the end of the year consistent with PDUFA guidelines.
Following NovaDel’s regulatory strategy, the company submitted the NDA using the 505(b) (2) […]
Nanomaterial Coatings Help Drugs Bypass Bodily Defenses
A new study published in the January issue of ACS Nano offers insight into cutting edge world of drug delivery research. In the study, UCLA and Northwestern University researchers used nanoscale polymer film coatings to circumvent typical bodily defenses while delivering a drug payload.
An inert nanoscale polymer film (‘orders of magnitude thinner’ than conventional drug […]
